CARDIO-PAD
®
Tablette Médicale Pour Les Examens Cardiaques et le Diagnostic à distance
Présenté par Mr. Arthur ZANG
Fondateur et Directeur General de Himore Medical S.A
INTRODUCTION
>> GENESIS OF THE PROBLEM
THE HEART
CARDIOVASCULAR
DISEASES
(CVD)
MAIN HUMAN BODY
ORGAN
Pumps blood to
other organs
INTRODUCTION
>> THE PROBLEM
CARDIOVASCULAR DISEASES
Globally
17.3 MILLION
DEATHS/YEAR
30% TOTAL MORTALITY
INTRODUCTION
>> BACKGROUND
CENTRAL AFRICA
1.2 Million deaths/year
22% Total Mortality
CENTRAL AFRICA
INTRODUCTION
>> THE SITUATION
FACTORS & CONSEQUENCES
CAMEROON
Total Patient Cost
II
SOLUTION:
Exams Cost
+
REMOTE
MEDICAL EXAMINATIONS
Transport
+
Housing
• Reduce CVD mortality
• Improve public health
Less than
40 CARDIOLOGISTS
for
More Than
20 MILLIONS PEOPLE
SOLUTION
OBJECTIVES
Perform ECG examinations in district hospitals
modest budget, located in rural areas, no specialist cardiologist
Reduce risks and costs for patients
Limited time and money
Facilitate the work of cardiologists
Remote interpretation and computer-assisted diagnosis ,
mobility in the workplace, better monitoring of patients
Management of biomedical data
Large Scale, treatment, and remote access of data
SOLUTION
LOCAL LEVEL
GLOBAL LEVEL
>> THE SOLUTION
THE CARDIO-PAD
Hospital
Recording
Cardiac exams with
the Cardio-pad,
Medical touch tablet
SOLUTION
>> CARDIOGLOB
ARCHITECTURE
GENESIS
CARDIOPAD TESTING RESULTS 2009-2010
Prof. Samuel Kingué
Cardiologist, medical
science department of
yaoundé
Prof. Claude Tangha
Polytechnic high school
Yaoundé
Prof. Pierre Tricot
Polytechnic school france
Arthur Zang
Creator of Cardio-Pad
Test File
Duration of
Signal
Overall Success: 97.7%
Total Number
of Heartbeats
Heartbeats
detected
False positives Heartbeats
undetected
Percentage
of success
100
60 secondes
74
74
0
0
100%
101
60 secondes
71
71
0
0
100%
102
60 secondes
73
72
0
1
98.63%
105
60 secondes
83
83
0
0
100%
210
60 secondes
93
97
4
0
95.69%
GENESIS
CARDIOPAD TESTING RESULTS 2010-2011
MASTER THESIS: CARDIOGLOB
DESIGN AND DEVELOPMENT OF SYSTEM FOR
ACQUISITION, PROCESSING AND TRANSMISSION
USING GSM OF CARDIAC SIGNAL.
Prof. Samuel Kingué et Prof. Claude Tangha
17.5 / 20
GENESE
MASTER DEGREE IN SOFWARE
DESIGN ENGINEERING
TWO SCIENTIFIC PUBLICATIONS
GENESE
AWARDS AND RECOGNITION
FEBRUARY 2011
MICROSOFT
SEMI-FINALISTS AT
IMAGINE CUP
COMPETITION
NOVEMBER 2011
ORANGE TELECOM
4th Place at African Social
Entrepreneur competition
CARDIO-PAD
Innovation and competition
DECEMBER 2011
FING ORGANISATION
Presented at “Carrefour des Possibles”
>> EXECUTION DU CHRONOGRAMME
3.B
FONCTIONNALITES DU CARDIOPAD
20 juin 2012 au 30/11/2012
Fonctionnalités
PADTRANSMIT
PadECGExam
PadECGScope
3,6,12 Pistes
ECGAnalyse
Transfert des
données
SOLUTION
>>ADVANTAGES OF THE SOLUTION
CONVENTIONAL ECG
DEVICES
Acquisition
Processing
Transmition
Storage
Remote monitoring
Remote diagnostic
Mobility
Average Price


X

X
X
X
$5 000
CARDIO-PAD







$2600
OURS CUSTOMERS
TARGET CUSTOMERS
BIG Hospitals
central and general
Hospitals
LABORATORIES
Performing exams
regardless of
interpretations
District Hospitals
Small rural hospital
without cardiologist
services
80 %
STATUS OF THE PROJECT
Prototype 2011
MANUFACTURING
First Tablet
MEDICAL DEVICES
MANUFACTURING COMPANY
Himore Medical founded in 2012 in
order to manufacture, commercialise
and bring to market the CARDIOGLOB
solution.
COMPANY BACKGROUND
7 Employees
Grant Funded with $25,000 usd
by the government of Cameroon
Private Investment of $5,000
Headquatered in Yaoundé,
Cameroon associated with the
University of Yaoundé
One Issued Patent
Under Contract with Public
Health Minister of Cameroon for
initial implementation of
Cardioglob
THE TEAM
HIMORE MEDICAL :
• 3 Software Engineers
•1 Biomedical Engineer
•2 Cardiologists
•1 Mathematician
STRATEGIC PARTNERS : Microsoft,
Embest, Quickembedd
30 Finished Products from first Manufacturing round
SOCIAL MEDIA MARKETING
FACEBOOK
YOUTUBE
>> CARDIOPAD IN THE NEWS
REVENUE MODEL
2012-2013
2013-2014
2014-2015
$20
$20
$20
x
x
x
8
7
5
x
x
x
30
60
100
x
x
x
No. working days
300
292
288
TOTAL. Annual
$1,440,000
$2,452,000
$2,880,000
Examination fee
Min.
Exam/Machine
Total No. of
Machine
PROFIT DISTRIBUTION
3,500,000
3,000,000
2,500,000
$921,600
$784,640
2,000,000
1,500,000
$460,800
1,000,000
500,000
0
$1,226,000
$1,440,000
$720,000
$259,200
$441,360
$518,400
2012-2013
2013-2014
2014-2015
Cardiologist 18%
Himore Medical 50%
Hospital 32%
Capital need
• Himore Medical seeks $500,000 in additional
investment to support further growth.
• Capital will be deployed as follows:
• $300,000 to support manufacturing and
distribution of the Cardiopad
• $200,000 to support development of future
products and generation of additional IP
Compelling investment highlights
• Strong Patent protection
• Attractive Market opportunity and unmet need
• Positive Social Impact
• Scalable Technology
• Innovative technology built on proven and
secure platform that reduces the investment
risks.
Contact
• Site : facebook.com/cardiopad
• Email : marc_arthur 2005@yahoo.fr
• Tél : (+237) 94 42 61 25
LES MEMBRES DU PROJET
•
•
•
•
ING. Arthur ZANG
Prof. Samuel KINGUE
ING. JEAN CEDRIC EVINA ONDOA
ING. JEAN PIERRE ANGUISSA ABESSOLO
CARDIO-PAD IN HOSPITAL